){kind=logo}
Loeb & Loeb is pleased to announce that Food & Drug Administration partner Jim Czaban, Mitch Nussbaum, vice chair of Loeb & Loeb and co-chair of the firm’s Capital Markets & Corporate department, and Mark Waddell, co-chair of the Life Sciences practice and chair of the Patent Litigation & Counseling practice, were recognized in the 2022 edition of the LMG Life Sciences rankings, a definitive guide to lawyers and law firms that specialize in the life sciences industry.
The rankings highlight firms and lawyers that specialize in four main practice areas: regulatory, intellectual property, financial and corporate, and non-IP litigation and enforcement.
Specifically, Jim was recognized in the FDA: Medical Device and FDA: Pharmaceutical categories, while Mitch was recognized in the Corporate category and Mark was recognized in the Patent Strategy & Management category.
For more information, please visit LMG Life Sciences’ website.
The rankings highlight firms and lawyers that specialize in four main practice areas: regulatory, intellectual property, financial and corporate, and non-IP litigation and enforcement.
Specifically, Jim was recognized in the FDA: Medical Device and FDA: Pharmaceutical categories, while Mitch was recognized in the Corporate category and Mark was recognized in the Patent Strategy & Management category.
For more information, please visit LMG Life Sciences’ website.
-
Co-Chair, Life Sciences -
乐博律所联席主席 -
Chair, Patent Litigation ＆ Counseling